Sign In
Buy LLY
$1,131.42
+6.04 (+0.537%)
At Close: Jun 05, 2026
Eli Lilly posts mixed quarter even as demand for weight loss, diabetes drugs soars
07:23am, Thursday, 06'th Feb 2025
CNBC's Angelica Peebles joins 'Squawk Box' to report on the company's quarterly earnings results.
Eli Lilly Stock Rises After Earnings Beat
07:01am, Thursday, 06'th Feb 2025
Fourth-quarter adjusted earnings of $5.32 a share beat analysts' estimates of $5.01.
Eli Lilly posts mixed quarter even as demand for weight loss, diabetes drugs soars
07:00am, Thursday, 06'th Feb 2025
Eli Lilly reported mixed results for the fourth quarter as sales of its blockbuster weight loss and diabetes drugs soared but saw lower realized prices. Demand in the U.S. has far outpaced supply for
Eli Lilly forecasts 2025 profit largely above estimates on launch of weight-loss drug in new markets
06:50am, Thursday, 06'th Feb 2025
Eli Lilly forecast annual profit largely above Wall Street estimates on Thursday, banking on the launch of its popular diabetes and weight-loss treatments in new markets.
Lilly reports full Q4 2024 financial results and provides 2025 guidance
06:45am, Thursday, 06'th Feb 2025
Revenue in Q4 2024 increased 45% to $13.53 billion driven by volume growth from Mounjaro and Zepbound. Non-incretin revenue(i) grew by 20% compared to Q4 2023.
Eli Lilly Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
03:03am, Thursday, 06'th Feb 2025
Eli Lilly and Company LLY will release its fourth-quarter financial results, before the opening bell, on Thursday, Feb. 6, 2025.
Eli Lilly Bulls Take Charge Ahead Of Q4 — Can It Reach $1000?
03:10pm, Wednesday, 05'th Feb 2025
Eli Lilly And Co LLY will be reporting its fourth-quarter earnings on Thursday. Wall Street expects $4.94 in EPS and $13.66 billion in revenues as the company reports before market hours.
Novo Nordisk CEO says firm's obesity pill could launch before Eli Lilly
10:00am, Wednesday, 05'th Feb 2025
Novo Nordisk CEO Lars Fruergaard Jørgensen weighs in the company's latest obesity drug offering, including its new oral weight loss candidate.
Lilly needs a plan to spur weight-loss drug sales, investors say
06:03am, Wednesday, 05'th Feb 2025
Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales of popular weight-loss drug Zepbound after it last month forecast lower-than
What Analysts Think of Eli Lilly Stock Ahead of Earnings
09:50pm, Tuesday, 04'th Feb 2025
Eli Lilly (LLY) is set to report fourth-quarter earnings before the bell Thursday, with analysts expecting rising sales and profit in the first full quarter since the company's weight-loss drugs were
What Thursday's Earnings Mean for This Pharma Giant
05:37pm, Tuesday, 04'th Feb 2025
Tomorrow, Eli Lilly (LLY), the world's largest drug company, reports earnings before the market opens. The options market is already predicting some major moves.
Healthy Returns: Why people quit weight loss, diabetes drugs within one year
02:48pm, Tuesday, 04'th Feb 2025
A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to focus on GLP-1 products.
What Analysts Think of Eli Lilly Stock Ahead of Earnings
01:40pm, Monday, 03'rd Feb 2025
Eli Lilly (LLY) is set to report fourth-quarter earnings before the bell Thursday, with analysts expecting rising sales and profit in the first full quarter since the company's weight-loss drugs were
Will These 5 Big Drug Stocks Surpass Q4 Earnings Forecasts?
12:20pm, Monday, 03'rd Feb 2025
Let's look at five pharma and drug companies, MRK PFE, LLY, AMGN and BMY, which are scheduled to release their fourth-quarter 2024 results later this week.
Curious about Lilly (LLY) Q4 Performance? Explore Wall Street Estimates for Key Metrics
10:20am, Monday, 03'rd Feb 2025
Evaluate the expected performance of Lilly (LLY) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics fo
